RSS   Newsletter   Contact   Advertise with us
Post Online Media

Regulus names Timothy M. Wright as R&D officer

Timothy M. WrightRegulus Therapeutics Inc., a biopharmaceutical company, announced the appointment of Timothy M. Wright as chief research and development (R&D) officer.
Article continues below

READ MORE Regulus Therapeutics promotes Mark Deeg to CMO

Dr. Wright joins Regulus from California Institute for Biomedical Research (Calibr), a not-for-profit translational research institute, where he was Executive Vice President of Translational Sciences since February 2015.

Prior to Calibr, Dr. Wright held a variety of positions with increasing levels of responsibility over an 11-year period at Novartis Pharma most recently as Global Head of Development.

Prior to Novartis, Dr. Wright spent three years at Pfizer holding leadership positions in Discovery and Clinical Sciences, leading translational research efforts and clinical trials for numerous programs across several therapeutic areas.

Dr. Wright was trained as a physician-scientist at Johns Hopkins and had an accomplished academic career at both Johns Hopkins and the University of Pittsburgh before moving to pharma.

He also serves as a key scientific advisor to several organizations, including the Bill & Melinda Gates Foundation.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy